Billionaire Profile
N
Global Rank
#955

Image: Vig, Peter Sorensen, 1854- [from old catalog] | Public domain | via Wikimedia Commons

Niels Peter Louis-Hansen

CEO, Medical devices
DENMARK
Real-Time Net Worth
$4.398B
Estimated based on Medical devices stock value as of March 6, 2026
-0.47% (24h)
Age
78
Source
Medical devices
Industry
Healthcare
Citizenship
DENMARK

Biography

Niels Peter Louis-Hansen, born in 1947, is a Danish industrialist and billionaire, best known for his significant role in Coloplast, a leading medical devices company. He serves as the deputy chairman and is the largest shareholder, with an estimated net worth of $4.8 billion as of February 2026. His wealth stems primarily from his long-term investment in Coloplast, which his father founded in 1957. Louis-Hansen has also invested in other healthcare and biotechnology companies in Denmark. His commitment to the healthcare sector and his strategic business approach have solidified his position as one of Denmark's wealthiest individuals.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Niels Peter Louis-Hansen was born on October 25, 1947, in Humlebæk, Denmark. He is the son of Aage Louis-Hansen and Johanne Louis-Hansen, who founded Coloplast in 1957. He grew up in a business-oriented family, which influenced his future career. After his father's death in 1966, he became involved in the family business and inherited a large portion of the company's ownership. He holds a degree in business economics.

Rise to Success

Louis-Hansen joined the Coloplast board in the 1970s and later became its deputy chairman. He played a key role in transforming the company from a family-controlled firm into a multinational public corporation. His leadership has been instrumental in Coloplast's growth, expanding its product portfolio and establishing it as a market leader in the medical devices sector. Through his investment vehicle, N.P. Louis-Hansen ApS, he owns approximately 20.7% of Coloplast's shares, making him the company's largest shareholder.

Key Business Strategies

Louis-Hansen's investment philosophy favors long-term stability and innovation in life sciences over short-term speculative growth. His strategic approach includes long-term ownership and disciplined corporate governance. He has also invested heavily in Denmark's healthcare and biotechnology industries, with stakes in Ambu A/S and ViroGates A/S.

Philanthropy

Louis-Hansen serves as chairman of the Aage and Johanne Louis-Hansen Foundation, which supports scientific research, medical development, cultural preservation, and architectural projects throughout Denmark. The foundation is one of the most active private donors in the country, promoting social responsibility alongside Danish design and innovation.

Career Milestones

1966

Board Member

Became a board member of Coloplast after his father's death.

1970s

Deputy Chairman

Became deputy chairman of Coloplast, overseeing the company's transition into a multinational corporation.

Philanthropy & Social Impact

Philanthropy

Aage and Johanne Louis-Hansen Foundation

Unknown

Supports scientific research, medical development, cultural preservation, and architectural projects.